Last reviewed · How we verify

NCT05045014

Evaluation of Vestibular Dysfunction or Visuospatial Perception in Individuals With Idiopathic Scoliosis

Status unknown Last updated 14 January 2022
What this trial tests

trial testing Balance assessment in Scoliosis Idiopathic in 84 participants. Status unknown.

Timeline
30 November 2021
Primary endpoint
15 April 2022
15 June 2022

Quick facts

Lead sponsorInonu University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment84
Start date30 November 2021
Primary completion15 April 2022
Estimated completion15 June 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Inonu University

Who can join

Adults 10 to 25, any sex, with Scoliosis Idiopathic or Vestibular Function Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned to investigate whether there is a visual-spatial perception disorder in individuals with idiopathic scoliosis and also to reveal its dependent/independent relationship with vestibular dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Balance assessment

Trials testing the same drug.

Other recruiting trials for Scoliosis Idiopathic

Currently open trials in the same condition.

Other Inonu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05045014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing